王倩, 张修磊, 郭肖岩. 山东省耐多药肺结核患者治疗转归情况分析[J]. 上海预防医学, 2021, 33(11): 1031-1034. DOI: 10.19428/j.cnki.sjpm.2021.20722
引用本文: 王倩, 张修磊, 郭肖岩. 山东省耐多药肺结核患者治疗转归情况分析[J]. 上海预防医学, 2021, 33(11): 1031-1034. DOI: 10.19428/j.cnki.sjpm.2021.20722
WANG Qian, ZHANG Xiu-lei, GUO Xiao-yan. Analysis of treatment outcomes of MDR-TB patients in Shandong Province[J]. Shanghai Journal of Preventive Medicine, 2021, 33(11): 1031-1034. DOI: 10.19428/j.cnki.sjpm.2021.20722
Citation: WANG Qian, ZHANG Xiu-lei, GUO Xiao-yan. Analysis of treatment outcomes of MDR-TB patients in Shandong Province[J]. Shanghai Journal of Preventive Medicine, 2021, 33(11): 1031-1034. DOI: 10.19428/j.cnki.sjpm.2021.20722

山东省耐多药肺结核患者治疗转归情况分析

Analysis of treatment outcomes of MDR-TB patients in Shandong Province

  • 摘要:
    目的分析2013—2017年山东省耐多药肺结核(multidrug resistant tuberculosis,MDR-TB)患者治疗转归情况,探讨全球基金耐多药防治项目(后称“项目”)结束对MDR-TB患者治疗转归的影响,为MDR-TB防治策略制定提供依据。
    方法从“结核病管理信息系统”收集2013—2017年山东省MDR-TB患者信息,利用Excel软件进行统计分析;描述性分析全省、5个项目市、非项目市MDR-TB发现患者数、纳入治疗率、成功治疗率;SPSS 16.0统计软件进行数据分析,率之间的比较采用χ2检验,P<0.05为差异有统计学意义。
    结果全省成功治疗率2014年最高(53.85%),2017年最低(22.93%),差异有统计学意义(χ2=40.96,P<0.001);全省纳入治疗率逐年增加,从66.97%增至85.06%,差异具有统计学意义(χ2=30.53,P<0.001);成功治疗率前4年均在46%以上,2017年下降至22.93%,差异具有统计学意义(χ2=40.96,P<0.001);患者丢失比例2014年后逐年上升,2017年达70.95%,差异具有统计学意义(χ2=2.32,P<0.001);2017年5个项目市发现患者数均为5年最低值。
    结论项目结束对山东省MDR-TB患者发现、治疗、管理均产生了影响,省级层面加大重视、积极探索针对MDR-TB的防治策略迫在眉睫。

     

    Abstract:
    ObjectivesTo analyze the outcome of treatment of patients with multidrug-resistant tuberculosis (MDR-TB) in Shandong Province from 2013 to 2017, and to discuss the impact of the global fund's multi-drug prevention and control program (hereinafter referred to as “ the Program”) on the outcome of treatment of MDR-TB patients, so as to provide a basis for the formulation of MDR-TB prevention and control strategy in Shandong Province.
    MethodsInformation of MDR-TB patients in Shandong Province from 2013 to 2017 was collected from the TB Management Information System, and Excel was used for statistical analysis. Descriptive analysis was conducted on the number of MDR-TB patients found, treatment rate, and successful treatment rate in the province, 5 project cities, and other non-project cities. SPSS16.0 statistical software was used for data analysis. Chi-square test was performed for comparison between rates (P<0.05).
    ResultThe successful treatment rate in the province was the highest in 2014 (53.85%) and the lowest in 2017(22.93%), with a statistically significant difference (χ2=40.96,P<0.001). The treatment rate in the whole province increased year by year, from 66.97% to 85.06%, and the difference was statistically significant (χ2=30.53,P<0.001). The successful treatment rate was above 46% every year between 2013 and 2016, and decreased to 22.93% in 2017, with a statistically significant difference (χ2=40.96,P<0.001). The proportion of lost patients increased year by year since 2014, reaching 70.95% in 2017, with a statistically significant difference (χ2=2.32,P<0.001). In 2017, the number of patients found in the five project cities was the lowest in five years.
    ConclusionThe result of the project has an impact on the discovery, treatment and management of MDR-TB patients in Shandong Province. There is an urgent need to pay more attention to and actively explore prevention and treatment strategies for MDR-TB at the provincial level.

     

/

返回文章
返回